Business Description
GeneTether Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA37187D1087
Description
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -122.4 | |||||
| 3-Year EPS without NRI Growth Rate | -91.3 | |||||
| 3-Year FCF Growth Rate | -86.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.6 | |||||
| 9-Day RSI | 57.61 | |||||
| 14-Day RSI | 52.97 | |||||
| 6-1 Month Momentum % | -25 | |||||
| 12-1 Month Momentum % | 200 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 36.4 | |||||
| Quick Ratio | 36.4 | |||||
| Cash Ratio | 35.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 5.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -44.11 | |||||
| ROA % | -42.51 | |||||
| ROIC % | -1285.62 | |||||
| ROC (Joel Greenblatt) % | -602.4 | |||||
| ROCE % | -47.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.94 | |||||
| Price-to-Tangible-Book | 0.9 | |||||
| EV-to-EBIT | -1.84 | |||||
| EV-to-EBITDA | -1.84 | |||||
| EV-to-FCF | -2.97 | |||||
| Price-to-Net-Current-Asset-Value | 0.9 | |||||
| Price-to-Net-Cash | 0.9 | |||||
| Earnings Yield (Greenblatt) % | -54.35 | |||||
| FCF Yield % | -35.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeneTether Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.011 | ||
| Beta | 0 | ||
| Volatility % | 179.42 | ||
| 14-Day RSI | 52.97 | ||
| 14-Day ATR (C$) | 0.000522 | ||
| 20-Day SMA (C$) | 0.045 | ||
| 12-1 Month Momentum % | 200 | ||
| 52-Week Range (C$) | 0.01 - 0.05 | ||
| Shares Outstanding (Mil) | 38.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GeneTether Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GeneTether Therapeutics Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
GeneTether Therapeutics Inc Frequently Asked Questions
What is GeneTether Therapeutics Inc(XCNQ:GTTX)'s stock price today?
The current price of XCNQ:GTTX is C$0.05. The 52 week high of XCNQ:GTTX is C$0.05 and 52 week low is C$0.01.
When is next earnings date of GeneTether Therapeutics Inc(XCNQ:GTTX)?
The next earnings date of GeneTether Therapeutics Inc(XCNQ:GTTX) is .
Does GeneTether Therapeutics Inc(XCNQ:GTTX) pay dividends? If so, how much?
GeneTether Therapeutics Inc(XCNQ:GTTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers